DBI / ACBP antibody
Principal name
DBI / ACBP antibody
Alternative names for DBI / ACBP antibody
Diazepam-binding inhibitor, Endozepine, Acyl-CoA-binding protein
Ncbi ID
NP_001073331, 9606, NP_065438, NP_001073331.1, NM_001037999, NM_001079862, NM_001079863, NM_001178043, NM_001178017, NM_031853, NM_001178042
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Enzyme Immunoassay (E), ELISA (detection) (E(detection)), Immunoprecipitation (IP), Frozen Sections (C), Paraffin Sections (P)
Background of DBI / ACBP antibody
DBI is diazepam binding inhibitor. The protein that is regulated by hormones and is involved in lipid metabolism and the displacement of beta-carbolines and benzodiazepines, which modulate sigl transduction at type A gamma-aminobutyric acid receptors located in brain sypses. DBI is conserved from yeast to mammals, with the most highly conserved domain consisting of seven contiguous residues that constitute the hydrophobic binding site for medium- and long-chain acyl-Coenzyme A esters. Diazepam binding inhibitor is also known to mediate the feedback regulation of pancreatic secretion and the postprandial release of cholecystokinin, in addition to its role as a mediator in corticotropin-dependent adrel steroidogenesis. Three pseudogenes located on chromosomes 6, 8 and 16 have been identified. Multiple transcript variants encoding different isoforms have been described for this gene. This gene encodes diazepam binding inhibitor, a protein that is regulated by hormones and is involved in lipid metabolism and the displacement of beta-carbolines and benzodiazepines, which modulate sigl transduction at type A gamma-aminobutyric acid receptors located in brain sypses. The protein is conserved from yeast to mammals, with the most highly conserved domain consisting of seven contiguous residues that constitute the hydrophobic binding site for medium- and long-chain acyl-Coenzyme A esters. Diazepam binding inhibitor is also known to mediate the feedback regulation of pancreatic secretion and the postprandial release of cholecystokinin, in addition to its role as a mediator in corticotropin-dependent adrel steroidogenesis. Three pseudogenes located on chromosomes 6, 8 and 16 have been identified. Multiple transcript variants encoding different isoforms have been described for this gene.
General readings
Folli F., et al. (2010) PLoS One. 5(3):e9923.
Manjithaya R., et al. (2010) J Cell Biol. 188(4):537-46.







Primary Antibodies
Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
---|---|---|---|---|---|---|---|
TA332222 | DBI / ACBP antibody |
||||||
Rabbit Polyclonal Anti-DBI Antibody | |||||||
![]() |
Rabbit | IgG | Purified | Bov, Can, GP, Hu, Ms, Rb, Rt | P, WB |
50 µg /
€360.00
|
|
OriGene Technologies, Inc. | |||||||
![]() |
|||||||
TA332648 | DBI / ACBP antibody |
||||||
Rabbit anti-DBI Polyclonal Antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Ms, Rt |
0.1 mg /
€335.00
|
||
OriGene Technologies, Inc. | |||||||
![]() |
CRISPR
Catalog No. | Species | Donor Vector | |
---|---|---|---|
KN208982 | DBI - human gene knockout kit via CRISPR |
||
![]() |
Human | GFP-Puro |
1 kit /
€1,290.00
|
OriGene Technologies, Inc. | |||
KN208982BN | DBI - human gene knockout kit via CRISPR |
||
![]() |
Human | mBFP-Neo |
1 kit /
€1,290.00
|
OriGene Technologies, Inc. |
Proteins & Growth Factors
Catalog No. | Species | Pres. | Purity | Source | |
---|---|---|---|---|---|
TP308982 | DBI / ACBP (transcript variant 1) |
||||
Recombinant protein of human diazepam binding inhibitor (GABA receptor modulator, acyl-Coenzyme A binding protein) (DBI), transcript variant 1 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€680.00
|
|
OriGene Technologies, Inc. | |||||
AR09477PU-L | DBI / ACBP (1-87, His-tag) |
||||
![]() |
Human | Purified | > 95 % by SDS - PAGE | E. coli |
0.5 mg /
€670.00
|
Acris Antibodies GmbH | |||||
AR09477PU-N | DBI / ACBP (1-87, His-tag) |
||||
![]() |
Human | Purified | > 95 % by SDS - PAGE | E. coli |
0.1 mg /
€250.00
|
Acris Antibodies GmbH |
Human Lenti ORF Particles
Mouse Lenti ORF Particles
Catalog No. | ||
---|---|---|
MR222491L2V | Lenti ORF particles, Dbi (GFP-tagged) - Mouse diazepam binding inhibitor (Dbi), transcript variant 1, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€907.00
|
|
OriGene Technologies, Inc. | ||
MR222491L1V | Lenti ORF particles, Dbi (Myc-DDK-tagged) - Mouse diazepam binding inhibitor (Dbi), transcript variant 1, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€804.00
|
|
OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
Catalog No. | ||
---|---|---|
RR214369L2V | Lenti ORF particles, Dbi (GFP-tagged ORF) - Rat diazepam binding inhibitor (GABA receptor modulator, acyl-Coenzyme A binding protein) (Dbi), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€907.00
|
|
OriGene Technologies, Inc. | ||
RR214369L1V | Lenti ORF particles, Dbi (Myc-DDK-tagged ORF) - Rat diazepam binding inhibitor (GABA receptor modulator, acyl-Coenzyme A binding protein) (Dbi), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€804.00
|
|
OriGene Technologies, Inc. | ||